NCT04322526 - Study of Naltrexone-Induced Blockade of Antidepressant Effects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

July 15, 2018

Study Completion Date

July 15, 2018

Conditions

DepressionMajor Depressive Disorder

Interventions

DRUG

Naltrexone 50 Mg Oral Tablet

Naltrexone hydrochloride (ReVia®. Toronto, ON: Teva Canada Limited; 2015) (onset of action: ≥15 minutes; peak effect: \~1 hour; duration: \~24 hours).

DRUG

Placebo oral tablet

Placebo tablet that has no inherent power to produce an effect. In the inert pill condition, participants will receive an oral placebo tablet.

Trial Locations (1)

15213

Bellefield Towers, Pittsburgh